Search

Anika Therapeutics Inc

Closed

SectorHealthcare

21.15 2.57

Overview

Share price change

24h

Current

Min

20.39

Max

21.31

Key metrics

By Trading Economics

Income

8.4M

3.3M

Sales

3M

33M

EPS

0.3

Profit margin

10.147

Employees

235

EBITDA

8.3M

4.9M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+0.67% upside

Dividends

By Acuity

Next Earnings

4 lis 2026

Market Stats

By TradingEconomics

Market Cap

80M

278M

Previous open

18.58

Previous close

21.15

News Sentiment

By Acuity

50%

50%

112 / 339 Ranking in Healthcare

Anika Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 wrz 2026, 19:16 UTC

Anika Therapeutics shares are advancing despite broader market volatility and renewed inflation concerns. No specific news was identified to explain today's price movement.

11 wrz 2026, 22:41 UTC

Anika Therapeutics Inc shares are lower in after-market hours, declining from earlier returns. The stock remains below its 20-day moving average and near recent lows.

10 wrz 2026, 20:07 UTC

Anika Therapeutics Inc. is higher today, with no specific news identified. The broader market remains flat amid recent interest rate hikes from the European Central Bank.

9 wrz 2026, 20:07 UTC

Anika Therapeutics Inc's shares are lower today, with no specific news identified. The stock remains below its 20-day moving average.

8 wrz 2026, 20:07 UTC

Anika Therapeutics shares are higher amid a broader market recovery, despite no specific company news driving the price movement.

3 wrz 2026, 20:07 UTC

Anika Therapeutics Inc shares declined during Thursday's session, reflecting ongoing selling pressure amid broader market dynamics and rising jobless claims.

2 wrz 2026, 20:08 UTC

Anika Therapeutics Inc shares are higher today, reflecting positive momentum despite no specific company news. The stock remains above its 20-day moving average.

1 wrz 2026, 19:11 UTC

Anika Therapeutics Inc is gaining today, despite earlier session pullbacks. Broader market movements reflect rising bond yields amid expectations for monetary tightening.

31 sie 2026, 22:16 UTC

Anika Therapeutics Inc shares are lower in after-market trading amid broader market concerns over inflation and potential interest rate hikes. No specific company news was identified.

28 sie 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, trading above the 20-day moving average and near the upper end of their one-month range.

27 sie 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market hours with no specific news identified for the decline. The stock has gained significantly over the past month.

26 sie 2026, 21:51 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains, despite no specific company news.

25 sie 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 sie 2026, 19:56 UTC

Anika Therapeutics Inc. shares are lower today amid broader market pressures, despite strong performance over the past month and trading above its 20-day moving average.

21 sie 2026, 21:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, showing unusual strength. No specific news was identified to explain this price movement.

20 sie 2026, 21:01 UTC

Anika Therapeutics shares are trading higher in after-market hours, showing steady gains since Thursday's close and remaining above the 20-day moving average.

19 sie 2026, 22:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading. No specific news was identified to explain the decline following Wednesday's close.

18 sie 2026, 20:06 UTC

Anika Therapeutics Inc's shares are higher during Tuesday's session, reflecting overall positive market performance, despite pulling back slightly from an earlier peak.

17 sie 2026, 20:06 UTC

Anika Therapeutics Inc shares are lower amid broader market declines, reflecting significant downward pressure following disappointing U.S. retail sales data for July.

14 sie 2026, 22:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

13 sie 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 sie 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 sie 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 sie 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 sie 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 sie 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 sie 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 sie 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 sie 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 lip 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

Peer Comparison

Price change

Anika Therapeutics Inc Forecast

Price Target

By TipRanks

0.67% upside

12 Months Forecast

Average 21 USD  0.67%

High 21 USD

Low 21 USD

Based on 2 Wall Street analysts offering 12 month price targets forAnika Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Sentiment

By Acuity

112 / 339 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
help-icon Live chat